| 000 | 01609 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517225757.0 | ||
| 264 | 0 | _c20191030 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0000000000001951 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdzhubei, Alexei A | |
| 245 | 0 | 0 |
_aModelling interaction between HIV-1 Nef and calnexin. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _c09 2018 |
||
| 300 |
_a2103-2111 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCalnexin _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xisolation & purification |
| 650 | 0 | 4 |
_aHIV-1 _xpathogenicity |
| 650 | 0 | 4 | _aHost-Pathogen Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aMolecular Dynamics Simulation |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aProtein Interaction Mapping |
| 650 | 0 | 4 |
_anef Gene Products, Human Immunodeficiency Virus _xantagonists & inhibitors |
| 700 | 1 | _aAnashkina, Anastasia A | |
| 700 | 1 | _aTkachev, Yaroslav V | |
| 700 | 1 | _aKravatsky, Yury V | |
| 700 | 1 | _aPushkarsky, Tatiana | |
| 700 | 1 | _aKulkarni, Amol | |
| 700 | 1 | _aMakarov, Alexander A | |
| 700 | 1 | _aBukrinsky, Michael I | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 32 _gno. 15 _gp. 2103-2111 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0000000000001951 _zAvailable from publisher's website |
| 999 |
_c28629320 _d28629320 |
||